Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Complex type 2 diabetes mellitus--management challenges and pitfalls.

Kennedy M, Roberts A.

Aust Fam Physician. 2013 Apr;42(4):207-10.

2.

Chronic kidney disease in type 2 diabetes patients in France: prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes.

Detournay B, Simon D, Guillausseau PJ, Joly D, Verges B, Attali C, Clement O, Briand Y, Delaitre O.

Diabetes Metab. 2012 Apr;38(2):102-12. doi: 10.1016/j.diabet.2011.11.005. Epub 2012 Jan 16. Review.

PMID:
22252014
3.

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.

PMID:
15799209
4.

Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?

Reddy SV, Bhatia E.

Natl Med J India. 2011 Jan-Feb;24(1):21-7. Review.

PMID:
21608354
5.

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment.

Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W.

Vasc Health Risk Manag. 2013;9:21-8. doi: 10.2147/VHRM.S39300. Epub 2013 Jan 23.

6.

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.

Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR.

Arch Intern Med. 2012 May 28;172(10):761-9. doi: 10.1001/archinternmed.2011.2230. Review. Erratum in: Arch Intern Med. 2012 Jul 23;172(14):1095.

7.

Type 2 diabetes and HbA1c targets.

[No authors listed]

Prescrire Int. 2008 Dec;17(98):254.

PMID:
19425272
8.

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.

Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S.

Ann Intern Med. 2011 Apr 19;154(8):554-9. doi: 10.7326/0003-4819-154-8-201104190-00007. Review.

PMID:
21502652
9.

What matters in ADVANCE and ADVANCE-ON.

Hamet P.

Diabetes Obes Metab. 2012 Jan;14 Suppl 1:20-9. doi: 10.1111/j.1463-1326.2011.01509.x. Review.

PMID:
22118707
10.

Type 2 diabetes comorbidities and treatment challenges: rationale for DPP-4 inhibitors.

Hollander PA, Kushner P.

Postgrad Med. 2010 May;122(3):71-80. doi: 10.3810/pgm.2010.05.2144.

PMID:
20463416
11.

New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals.

Wysham CH.

Postgrad Med. 2010 May;122(3):52-60. doi: 10.3810/pgm.2010.05.2142.

PMID:
20463414
12.

Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.

Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ.

Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.

PMID:
21883672
13.

Managing diabetes from first diagnosis: choosing well-tolerated therapies with durability.

Kruger DF.

Diabetes Educ. 2012 Jul-Aug;38(4 Suppl):4S-11S; quiz 12S. doi: 10.1177/0145721712450619. Epub 2012 Jun 19. Review.

PMID:
22713263
14.

Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.

Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, Kaplan SH.

Ann Intern Med. 2009 Dec 15;151(12):854-60. doi: 10.7326/0003-4819-151-12-200912150-00005.

PMID:
20008761
15.
17.

Type 2 diabetic patient-centered care.

Prueksaritanond S, Tubtimtes S, Asavanich K, Tiewtranon V.

J Med Assoc Thai. 2004 Apr;87(4):345-52.

PMID:
15217167
18.

Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted?

Ferguson LD, Sattar N.

Diabetes Obes Metab. 2013 May;15(5):387-91. doi: 10.1111/dom.12018. Epub 2012 Nov 1. Review.

PMID:
23020636
19.

Intensive glycemic control and cardiovascular disease: are there patients who may benefit?

Chokrungvaranon N, Deer J, Reaven PD.

Postgrad Med. 2011 Nov;123(6):114-23. doi: 10.3810/pgm.2011.11.2501. Review.

PMID:
22104460
20.

Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.

Monnier L, Colette C, Owens DR.

Diabetes Metab Res Rev. 2009 Jul;25(5):393-402. doi: 10.1002/dmrr.962. Review.

PMID:
19437415

Supplemental Content

Support Center